[1] 中华医学会感染病学分会,中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版). 中华肝脏病杂志,2019,27(12):938-961.
[2] 中华医学会肝病学分会. 扩大慢性乙型肝炎抗病毒治疗的专家意见. 中华肝脏病杂志,2022,30(2):131-136.
[3] Tong MJ, Hsien C, Hsu L, et al. Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States. Hepatology, 2008, 48(4):1070-1078.
[4] Sinn DH, Kim SE, Kim BK, et al. The risk of hepatocellular carcinoma among chronic hepatitis B virus-infected patients outside current treatment criteria. J Viral Hepat, 2019, 26(12):1465-1472.
[5] de Franchis R, Hadengue A, Lau G, et al. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). J Hepatol, 2003, 39 Suppl 1:S3-25.
[6] Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol, 2006,4(8):936-962.
[7] ACT-HBV Asia-Pacifific Steering Committee Members. Chronic hepatitis B: treatment alert. Liver Int, 2006, 26:47-58.
[8] Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology, 2007, 45:507- 539.
[9] Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int, 2016, 10(1):1-98.
[10] European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol, 2017, 67(2):370-398.
[11] Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology, 2018, 67(4):1560-1599.
[12] 鲁凤民,封波,郑素军,等. 核苷(酸)类似物经治的慢性乙型肝炎患者低病毒血症的研究现状. 临床肝胆病杂志, 2021, 37(6):1268-1274.
[13] Sun Y, Wu X, Zhou J, et al. Persistent low level of hepatitis B virus promotes ?brosis progression during therapy. Clin Gastroenterol Hepatol, 2020, 18(11): 2582-2591.
[14] Zhang Q, Peng H, Liu X, et al. Chronic hepatitis B infection with low level viremia correlates with the progression of the liver disease. J Clin Transl Hepatol, 2021, 9(6):850-859.
[15] Jang JW, Choi JY, Kim YS, et al. Effects of virologic response to treatment on short- and long-term outcomes of patients with chronic hepatitis B virus infection and decompensated cirrhosis. Clin Gastroenterol Hepatol, 2018, 16(12): 1954-1963.
[16] Iloeje UH, Yang HI, Chen CJ, et al. Natural history of chronic hepatitis B: what exactly has REVEAL revealed? Liver Int, 2012, 32(9): 1333-1341.
[17] Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA,2006, 295(1):65-73. |
